ChristineEllenCoddingMD

Rheumatology • Oklahoma City, OK

Physician

Join to view full profile

Dr. Codding is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Codding's full profile

Already have an account?

Office
1211 North Shartel Avenue
Suite 700
Oklahoma City, OK 73103
Phone+1 405-702-6700

Fax+1 405-702-6720

Education & Training

University of Oklahoma Health Sciences CenterFellowship, Rheumatology, 1989 - 1991
University of Oklahoma Health Sciences CenterResidency, Internal Medicine, 1986 - 1989
University of Oklahoma College of MedicineClass of 1986

Certifications & Licensure

OK State Medical License 1987 - 2025

Awards, Honors, & Recognition

Top MD Consumers Checkbook
Fellow (FACR) American College of Rheumatology

Clinical Trials

A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor Start of enrollment: 2013 Jul 01
Completed
Phase 2
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2013 Jun 27
Completed
Phase 3
Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2012 Jun 01
Completed
Phase 2
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) Start of enrollment: 2014 Jun 16
Completed
Phase 3
Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis Start of enrollment: 2015 Feb 21
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

13 citations
Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study
Mark C. Genovese, Maria Greenwald, Sergio R Gutierrez-Ureña, Mario H. Cardiel, J. Poiley
Rheumatology and Therapy. 2019-08-13
133 citations
Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double-Blind, Active Comparator- and Placebo-Controlled Study.
Francisco J. Blanco, Rüdiger Möricke, Eva Dokoupilova, Christine E Codding, Jeffrey Neal
Arthritis & Rheumatology. 2017-06-01
227 citations
Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study
Iain B. McInnes, Liz Thompson, Jon T. Giles, Joan M. Bathon, Jane E. Salmon
Annals of the Rheumatic Diseases. 2015-04-01

Professional Memberships

American College of Rheumatology - ACR
Fellow